Human prostate steroid hormone receptor quantitation. Current methodology and possible utility as a clinical discriminant in carcinoma.
D000230:Adenocarcinoma / Q000032:analysis / Q000188:drug therapy* / Q000378:metabolism; D000818:Animals; D001667:Binding, Competitive; D001943:Breast Neoplasms / Q000378:metabolism; D003593:Cytoplasm / Q000032:analysis / Q000378:metabolism; D003600:Cytosol / Q000032:analysis / Q000378:metabolism; D004285:Dogs; D005260:Female; D006801:Humans; D008297:Male; D008722:Methods; D011467:Prostate / Q000032:analysis* / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000032:analysis / Q000188:drug therapy* / Q000378:metabolism; D011485:Protein Binding; D011944:Receptors, Androgen / Q000032:analysis* / Q000378:metabolism; D011960:Receptors, Estrogen / Q000032:analysis / Q000378:metabolism; D011987:Receptors, Steroid / Q000032:analysis*
D011944:Receptors, Androgen; D011960:Receptors, Estrogen; D011987:Receptors, Steroid